Chronic hepatitis C virus (HCV) is relatively common among some subpopulations who are co-infected with HIV. HCV can be cured in more than 95% of people with the use of potent combinations of drugs such as the following: Chronic viral infections such as HCV and HIV can cause excess inflammation and activation of the immune…
Category: News-en
With support from ViiV Healthcare and the assistance of amfAR’s public policy team, amfAR’s TREAT Asia program has launched CLM Asia, an online data dashboard to enhance ongoing community-led monitoring in India and Indonesia. Community-led monitoring or CLM is a practice that enables people living with or affected by HIV and Hepatitis Virus to provide…
Friends, we would like to inform you that after a peaceful demonstration with other community members on May 29, 2023, Daclatasvir is finally available via emergency purchase. On 31 May 2023, the Hepatitis Working Team invited us and the Provincial Health Office to inform the distribution plan. Today, June 1, 2023, Daclatasvir 60 mg for…
by Caroline Thomas 12 April 2023 Today we had the opportunity to be part of the team for development of standards for communicable disease, especially HIV-TB, at the Technical Implementation Units for Correctional Facilities. Why is it important for us to be involved in HIV and TB issues? Despite the fact that most of the…
Jakarta, 6 April 2023 World Hepatitis Day which is celebrated every July 28 has a theme for 2 consecutive years regarding bringing Hepatitis service access closer because Hepatitis cannot wait. Indonesia itself adopted this theme and in 2022 the Government launched the theme “Towards a Generation Free of Hepatitis”. This theme highlights the injustices caused…